Efficacy and safety of first-line immunotherapy for advanced gastric or gastroesophageal cancer: System review network meta-analysis

被引:0
|
作者
Qin, Qiong
Sun, Yongkun
Yang, Lin
Zhong, Diansheng
机构
[1] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16014
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Efficacy of first-line combination therapies versus gemcitabine monotherapy for advanced pancreatic cancer: a systematic review and network meta-analysis
    Huang, Wen-Kuan
    Hung, Yu-Liang
    Tsai, Chun-Yi
    Wu, Chiao-En
    Chou, Wen-Chi
    Hsu, Jun-Te
    Yeh, Ta-Sen
    Chen, Jen-Shi
    Wang, Shang-Yu
    Yeh, Chun-Nan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (07):
  • [42] Efficacy and safety of the first-line systemic treatments in patients with advanced-stage urothelial carcinoma: a systematic review and network meta-analysis
    Zhao, Yang
    Xu, Xiaoqing
    Sun, Yuhan
    Yu, Xinyang
    Qi, Yuanfu
    Dai, Xin
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [43] Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Cancer: a Bayesian Network Meta-Analysis
    Zhu, Lucheng
    Liu, Jihong
    MA, Shenglin
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (04) : 853 - 861
  • [44] First-Line Immunotherapy Combinations in Advanced Renal Cell Carcinoma: A Rapid Review and Meta-Analysis
    Shpilsky, Jason
    Catalano, Paul J.
    McDermott, David F.
    KIDNEY CANCER, 2021, 5 (03) : 153 - 163
  • [45] Efficacy and Safety of Various First-Line Therapeutic Strategies for Fetal Tachycardias: A Network Meta-Analysis and Systematic Review
    Qin, Jiangwei
    Deng, Zhengrong
    Tang, Changqing
    Zhang, Yunfan
    Hu, Ruolan
    Li, Jiawen
    Hua, Yimin
    Li, Yifei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [46] First-line treatment options for advanced gastric/gastroesophageal junction cancer patients with PD-L1-positive: a systematic review and meta-analysis
    Fan, Ling
    Lu, Ning
    Zhang, Lingmin
    Zhang, Jie
    Li, Jie
    Cui, Manli
    Zhang, Mingxin
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (06): : 2875 - 2883
  • [47] Efficacy and safety of Nivolumab in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized controlled trials
    Xinming Lei
    Weimin Huo
    Tian Xu
    Jianguang Xu
    Maoning Liu
    Chengjiang Liu
    Zhangyuan Gu
    BMC Gastroenterology, 24 (1)
  • [48] Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis
    Jinming Li
    Guoshuang Shen
    Miaozhou Wang
    Xingfa Huo
    Fuxing Zhao
    Dengfeng Ren
    Yi Zhao
    Jiuda Zhao
    Clinical and Experimental Medicine, 2023, 23 : 1489 - 1499
  • [49] Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis
    Li, Jinming
    Shen, Guoshuang
    Wang, Miaozhou
    Huo, Xingfa
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Yi
    Zhao, Jiuda
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (05) : 1489 - 1499
  • [50] A Network Meta-analysis of the Efficacy of Drug Therapy in First-line Treatment of Advanced Hepatocellular Carcinoma
    Wang, Xinchou
    Peng, Gaoyao
    Li, Jiangfa
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2024, 33 (01) : 94 - 101